About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
DELIVERABLE VOLUME
Deliverable
Volume
Glenmark Pharmaceuticals Ltd.
BSE Code
532296
ISIN Demat
INE935A01035
Book Value
848.58
NSE Code
GLENMARK
Dividend Yield %
0.16
Market Cap
435232.90
P/E
7.71
EPS
199.94
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Total Volume
Deliverable Volume
Deliverable Volume [%]
20-Dec-2024
9138
4188
45.83
19-Dec-2024
7886
1989
25.22
18-Dec-2024
9274
1757
18.95
17-Dec-2024
13184
4484
34.01
16-Dec-2024
13307
4186
31.46
13-Dec-2024
52871
4437
8.39
12-Dec-2024
298220
286751
96.15
11-Dec-2024
11297
3983
35.26
10-Dec-2024
41328
13866
33.55
09-Dec-2024
14171
4006
28.27
06-Dec-2024
11719
6084
51.92
05-Dec-2024
12780
2796
21.88
04-Dec-2024
6721
2074
30.86
03-Dec-2024
10125
3167
31.28
02-Dec-2024
11248
2170
19.29
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.